{
  "PMC": "6275757",
  "DOI": "10.2478/s11658-006-0063-x",
  "PMID": "17180310",
  "PMCID": "PMC6275757",
  "title": "Genetic instability in the RAD51 and BRCA1 regions in breast cancer.",
  "year": 2007,
  "source_url": "https://europepmc.org/article/PMC/PMC6275757",
  "source": "MED",
  "abstract_text": "Breast cancer is the most prevalent cancer type in women. Accumulating evidence indicates that the fidelity of double-strand break repair in response to DNA damage is an important step in mammary neoplasias. The RAD51 and BRCA1 proteins are involved in the repair of double-strand DNA breaks by homologous recombination. In this study, we evaluated loss of heterozygosity (LOH) in the RAD51 and BRCA1 regions, and their association with breast cancer. The polymorphic markers D15S118, D15S214 and D15S1006 were the focus for RAD51, and D17S855 and D17S1323 for BRCA1. Genomic deletion detected by allelic loss varied according to the regions tested, and ranged from 29 to 46% of informative cases for the RAD51 region and from 38 to 42% of informative cases for the BRCA1 region. 25% of breast cancer cases displayed LOH for at least one studied marker in the RAD51 region exclusively. On the other hand, 31% of breast cancer cases manifested LOH for at least one microsatellite marker concomitantly in the RAD51 and BRCA1 regions. LOH in the RAD51 region, similarly as in the BRCA1 region, appeared to correlate with steroid receptor status. The obtained results indicate that alteration in the RAD51 region may contribute to the disturbances of DNA repair involving RAD51 and BRCA1 and thus enhance the risk of breast cancer development.",
  "full_text": "Cell Mol Biol Lett Cell. Mol. Biol. Lett Cellular & Molecular Biology Letters 1425-8153 1689-1392 Versita Warsaw 6275757 17180310 63 10.2478/s11658-006-0063-x Article Genetic instability in the RAD51 and BRCA1 regions in breast cancer Nowacka-Zawisza Maria 1 Bryś Magdalena 1 Romanowicz-Makowska Hanna 2 Kulig Andrzej 2 Krajewska Wanda M. +48-42-6354487 +48-42-6354484 wmkraj@biol.uni.lodz.pl 1 1 grid.10789.37 0000000097302769 Department of Cytobiochemistry, University of Łódź, Banacha 12/16, 90-237 Łódź, Poland 2 Department of Clinical Pathomorphology, Polish Mother’s Memorial Hospital, Research Institute, Rzgowska 281/289, 93-338 Łódź Poland 18 12 2006 4 2007 12 2 192 205 24 5 2006 26 9 2006 © University of Wrocław 2006 Breast cancer is the most prevalent cancer type in women. Accumulating evidence indicates that the fidelity of double-strand break repair in response to DNA damage is an important step in mammary neoplasias. The RAD51 and BRCA1 proteins are involved in the repair of double-strand DNA breaks by homologous recombination. In this study, we evaluated loss of heterozygosity (LOH) in the RAD51 and BRCA1 regions, and their association with breast cancer. The polymorphic markers D15S118, D15S214 and D15S1006 were the focus for RAD51 , and D17S855 and D17S1323 for BRCA1 . Genomic deletion detected by allelic loss varied according to the regions tested, and ranged from 29 to 46% of informative cases for the RAD51 region and from 38 to 42% of informative cases for the BRCA1 region. 25% of breast cancer cases displayed LOH for at least one studied marker in the RAD51 region exclusively. On the other hand, 31% of breast cancer cases manifested LOH for at least one microsatellite marker concomitantly in the RAD51 and BRCA1 regions. LOH in the RAD51 region, similarly as in the BRCA1 region, appeared to correlate with steroid receptor status. The obtained results indicate that alteration in the RAD51 region may contribute to the disturbances of DNA repair involving RAD51 and BRCA1 and thus enhance the risk of breast cancer development. Key words RAD51 BRCA1 Loss of heterozygosity (LOH) Breast cancer issue-copyright-statement © University of Wrocław 2007 Abbreviations used AML acute myeloid leukemia BACH1 helicase BRCA1 interacting protein C-terminal helicase 1 [ Homo sapiens ] BRCA1 breast cancer susceptibility gene 1 BRCT BRCA C-terminus LOH loss of heterozygosity RecA RecA protein (Recombinase A) MRE11 meiotic recombination 11 homologue A NBS1 Nijmegen breakage syndrome 1 (nibrin, NBN) p53 tumor protein 53 RAD50 RAD50 homologue ( Saccharomyces cerevisiae ) [ Homo sapiens ] RAD51 RAD51 homologue (RecA homologue, Escherichia coli ) ( Saccharomyces cerevisiae ) [ Homo sapiens ] RAD52 RAD52 homologue ( Saccharomyces cerevisiae ) [ Homo sapiens ] t-AML therapy related AML References 1. Nathanson K.L. Weber B.L. \"Other\" breast cancer susceptibility genes: searching for more holy grail Hum. Mol. Genet 2001 10 715 720 10.1093/hmg/10.7.715 11257104 2. Welcsh P.L. King M.C. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer Hum. Mol. Genet. 2001 10 705 713 10.1093/hmg/10.7.705 11257103 3. Auranen A. Song H. Waterfall C. Dicioccio R.A. Kuschel B. Kjaer S.K. Hogdall E. Hogdall C. Stratton J. Whittemore A.S. Easton D.F. Ponder B.A. Novik K.L. Dunning A.M. Gayther S. Pharoah P.D. Polymorphisms in DNA repair genes and epithelial ovarian cancer risk Int. J. Cancer 2005 117 611 618 10.1002/ijc.21047 15924337 4. Cousineau I. Abaji C. Belmaaza A. BRCA1 regulates RAD51 function in response to DNA damage and suppresses spontaneous sister chromatid replication slippage: implications for sister chromatid cohesion, genome stability, and carcinogenesis Cancer Res. 2005 65 11384 11391 10.1158/0008-5472.CAN-05-2156 16357146 5. Schmutte C. Tombline G. Rhiem K. Sadoff M.M. Schmutzler R. von Deimling A. Fishel R. Characterization of the human Rad51 genomic locus and examination of tumors with 15q14-15 loss of heterozygosity (LOH) Cancer Res. 1999 59 4564 4569 10493508 6. Shinohara A. Ogawa H. Matsuda Y. Ushio N. Ikoe K. Ogawa T. Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA Nature Genet. 1993 4 239 243 10.1038/ng0793-239 8358431 7. Takahashi E. Matsuda Y. Hori T. Yasuda N. Tsuji S. Mori M. Yoshimura Y. Yamamoto A. Morita T. Matsushiro A. Chromosome mapping of the human (RECA) and mouse (Reca) homologs of the yeast RAD51 and Escherichia coli recA genes to human (15q15.1) and mouse (2F1) chromosomes by direct R-banding fluorescence in situ hybridization Genomics 1994 19 376 378 10.1006/geno.1994.1074 8188269 8. Benson F.E. Stasiak A. West S.C. Purification and characterization of the human Rad51 protein, an analogue of E. coli RecA EMBO J. 1994 13 5764 5771 7988572 9. Baumann P. Benson F.E. West S.C. Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro Cell 1996 87 757 766 10.1016/S0092-8674(00)81394-X 8929543 10. Gupta R. Bazemore L.R. Golub E.I. Radding C.M. Activities of human recombination protein Rad51 Proc Natl. Acad. Sci. USA 1997 94 463 468 9012806 11. Yamamoto A. Taki T. Yagi H. Habu T. Yoshida K. Yoshimura Y. Yamamoto K. Matsushiro A. Nishimune Y. Morita T. Cell cycledependent expression of the mouse Rad51 gene in proliferating cells Mol. Gen. Genet. 1996 251 1 12 8628240 12. Chen F. Nastasi A. Shen Z. Brenneman M. Crissman H. Chen D.J. Cell cycle-dependent protein expression of mammalian homologs of yeast DNA double-strand break repair genes Rad51 and Rad52 Mutat. Res. 1997 384 205 211 9330616 13. Xia S.J. Shammas M.A. Shmookler Reis R.J. Elevated recombination in immortal human cells is mediated by HsRAD51 recombinase Mol. Cell. Biol. 1997 17 7151 7158 9372947 14. Shen Z. Cloud K.G. Chen D.J. Park M.S. Specific interactions between the human RAD51 and RAD52 proteins J. Biol. Chem. 1996 271 148 152 10.1074/jbc.271.1.148 8550550 15. Sturzbecher H.W. Donzelmann B. Henning W. Knippschild U. Buchhop S. p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction EMBO J. 1996 15 1992 2002 8617246 16. Buchhop S. Gibson M.K. Wang X.W. Wagner P. Sturzbecher H.W. Harris C.C. Interaction of p53 with the human Rad51 protein Nucleic Acids Res. 1997 25 3868 3874 10.1093/nar/25.19.3868 9380510 17. Wong A.K. Pero R. Ormonde P.A. Tavtigian S.V. Bartel P.L. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2 J. Biol. Chem. 1997 272 31941 31944 10.1074/jbc.272.51.31941 9405383 18. Marmorstein L.Y. Ouchi T. Aaronson S.A. The BRCA2 gene product functionally interacts with p53 and RAD51 Proc. Natl. Acad. Sci. USA. 1998 95 13869 13874 10.1073/pnas.95.23.13869 9811893 19. Scully R. Chen J. Plug A. Xiao Y. Weaver D. Feunteun J. Ashley T. Livingston D.M. Association of BRCA1 with Rad51 in mitotic and meiotic cells Cell 1997 188 265 275 10.1016/S0092-8674(00)81847-4 20. Zhong Q. Chen C.F. Li S. Chen Y. Wang C.C. Xiao J. Chen P.L. Sharp Z.D. Lee W.H. Association of BRCA1 with the hRad50--hMre11-p95 complex and the DNA damage response Science 1999 285 747 750 10.1126/science.285.5428.747 10426999 21. Hall J.M. Lee M.K. Newman B. Morrow J.E. Anderson L.A. Huey B. King M.C. Linkage of early-onset familial breast cancer to chromosome 17q21 Science 1990 250 1684 1689 10.1126/science.2270482 2270482 22. Miki Y. Swensen J. Shattuck-Eidens D. Futreal P.A. Harshman K. Tavtigian S. Liu Q. Cochran C. Bennett L.M. Ding W. Bell R. Rosenthal J. Hussey C. Tran T. McClure M. Frye C. Hattier T. Phelps R. Haugen-Strano A. Katcher H. Yakumo K. Gholami Z. Shaffer D. Stone S. Bayer S. Wray C. Bogden R. Dayananth P. Ward J. Tonin P. Narod S. Bristow P.K. Norris F.H. Helvering L. Morrison P. Rosteck P. Lai M. Barrett J.C. Lewis C. Neuhausen S. Cannon-Albright L. Goldgar D. Wiseman R. Kamb A. Skolnick M.H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 Science 1994 266 66 71 10.1126/science.7545954 7545954 23. Monteiro A.N. August A. Hanafusa H. Evidence for a trans-criptional activation function of BRCA1 C-terminal region Proc. Natl. Acad. Sci. USA 1996 93 13595 13599 10.1073/pnas.93.24.13595 8942979 24. Huyton T. Bates P.A. Zhang X. Sternberg M.J. Freemont P.S. The BRCA1 C-terminal domain: structure and function Mutat. Res. 2000 460 319 332 10946236 25. Koonin E.V. Altschul S.F. Bork P. BRCA1 protein products … Functional motifs… Nat. Genet. 1996 13 266 268 10.1038/ng0796-266 8673121 26. Bork P. Hofmann K. Bucher P. Neuwald A.F. Altschul S.F. Koonin E.V. A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins FASEB J. 1997 11 68 76 9034168 27. Larson J.S. Tonkinson J.L. Lai M.T. A BRCA1 mutant alters G2-M cell cycle control in human mammary epithelial cells Cancer Res. 1997 57 3351 3355 9269994 28. Moynahan M.E. Chiu J.W. Koller B.H. Jasin M. Brca1 controls homology-directed DNA repair Mol. Cell 1999 4 511 518 10.1016/S1097-2765(00)80202-6 10549283 29. Scully R. Livingston D.M. In search of the tumour-suppressor functions of BRCA1 and BRCA2 Nature 2000 408 429 432 10.1038/35044000 11100717 30. Wang Y. Cortez D. Yazdi P. Neff N. Elledge S.J. Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures Genes Dev. 2000 14 927 939 10783165 31. Cantor S.B. Bell D.W. Ganesan S. Kass E.M. Drapkin R. Grossman S. Wahrer D.C. Sgroi D.C. Lane W.S. Haber D.A. Livingston D.M. BACH1, a novel helicase-like protein, interacts directly with BRCA1 and contributes to its DNA repair function Cell 2001 105 149 160 10.1016/S0092-8674(01)00304-X 11301010 32. Garcia-Higuera I. Taniguchi T. Ganesan S. Meyn M.S. Timmers C. Hejna J. Grompe M. D’Andrea A.D. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway Mol. Cell 2001 7 249 262 10.1016/S1097-2765(01)00173-3 11239454 33. Franchitto A. Pichierri P. Bloom’s syndrome protein is required for correct relocalization of RAD50/MRE11/NBS1 complex after replication fork arrest J. Cell Biol. 2002 157 19 30 10.1083/jcb.200110009 11916980 34. Liu Y. West S.C. Distinct functions of BRCA1 and BRCA2 in doublestrand break repair Breast Cancer Res. 2002 4 9 13 10.1186/bcr417 11879553 35. Manke I.A. Lowery D.M. Nguyen A. Yaffe M.B. BRCT repeats as phosphopeptide-binding modules involved in protein targeting Science 2003 302 636 639 10.1126/science.1088877 14576432 36. Yu X. Chini C.C. He M. Mer G. Chen J. The BRCT domain is a phospho-protein binding domain Science 2003 302 639 642 10.1126/science.1088753 14576433 37. Beckmann M.W. Schnurch H.G. Bodden-Heidrich R. Mosny D.S. Crombach G. Nitz U. Achnoula M. Bender H.G. Early cancer detection programmes for women at high risk for breast and ovarian cancer: a proposal of practical guidelines Eur. J. Cancer Prev. 1996 5 468 475 9061278 38. Hanby A.M. Kelsell D.P. Potts H.W. Gillett C.E. Bishop D.T. Spurr N.K. Barnes D.M. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer Int. J. Cancer 2000 88 204 208 10.1002/1097-0215(20001015)88:2<204::AID-IJC9>3.0.CO;2-1 11004669 39. Wright, D.K. and Manson, M.M. Sample preparation from paraffinembedded tissues. in: PCR Protocols: A Guide to Methods and Application, (Innis, M.A., Ed.), Academic Press, Inc., 1990, 153–156. 40. Rolfs, A., Schuller, I., Finckh, U. and Weber-Rolfs, J. PCR: clinical diagnostic and research. Springer Lab., 1992, 81–84. 41. Cawkwell L. Bell S.M. Lewis F.A. Dixon M.F. Taylor G.R. Quirke P. Rapid detection of allele loss in colorectal tumours using microsatellites and fluorescent DNA technology Br. J. Cancer 1993 67 1262 1267 8512811 42. Simpson A.J. The natural somatic mutation frequency and human carcinogenesis Adv. Cancer Res. 1997 71 209 240 10.1016/S0065-230X(08)60100-1 9111867 43. Thiagalingam S. Foy R.L. Cheng K. Lee H.J. Thiagalingam A. Ponte J.F. Loss of heterozygosity as a predictor to map tumor suppressor genes in cancer: molecular basis of its occurrence Curr. Opin. Oncol. 2002 14 65 72 10.1097/00001622-200201000-00012 11790983 44. Chen J.J. Silver D. Cantor S. Livingston D.M. Scully R. BRCA1, BRCA2, and Rad51 operate in a common DNA damage response pathway Cancer Res. 1999 59 1752s 1756s 10197592 45. Dasika G.K. Lin S.C. Zhao S. Sung P. Tomkinson A. Lee E.Y. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis Oncogene 1999 18 7883 7899 10.1038/sj.onc.1203283 10630641 46. Wang W.W. Spurdle A.B. Kolachana P. Bove B. Modan B. Ebbers S.M. Suthers G. Tucker M.A. Kaufman D.J. Doody M.M. Tarone R.E. Daly M. Levavi H. Pierce H. Chetrit A. Yechezkel G.H. Chenevix-Trench G. Offit K. Godwin A.K. Struewing J.P. A single nucleotide polymorphism in the 5′ untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers Cancer Epidemiol. Biomarkers Prev. 2001 10 955 960 11535547 47. Levy-Lahad E. Lahad A. Eisenberg S. Dagan E. Paperna T. Kasinetz L. Catane R. Kaufman B. Beller U. Renbaum P. Gershoni-Baruch R. A single nucleotide polymorphism in the RAD51 gene modifies cancer risk in BRCA2 but not BRCA1 carriers Proc. Natl. Acad. Sci. USA. 2001 98 3232 3236 10.1073/pnas.051624098 11248061 48. Goode E.L. Dunning A.M. Kuschel B. Healey C.S. Day N.E. Ponder B.A. Easton D.F. Pharoah P.P. Effect of germ-line genetic variation on breast cancer survival in a population-based study Cancer Res. 2002 62 3052 3057 12036913 49. Błasiak J. Przybyłowska K. Czechowska A. Zadrożzny M. Pertyński T. Rykała J. Kołacińska A. Morawiec Z. Drzewoski J. Analysis of the G/C polymorphism in the 5′-untranslated region of the RAD51 gene in breast cancer Acta Biochim. Pol. 2003 50 249 253 12673366 50. Romanowicz-Makowska H. Smolarz B. Kulig A. Germline BRCA1 mutations and G/C polymorphism in the 5′-untranslated region of the RAD51 gene in Polish women with breast cancer Pol. J. Pathol. 2005 56 161 165 16477874 51. Jakubowska A. Narod S.A. Goldgar D.E. Mierzejewski M. Masojc B. Nej K. Huzarska J. Byrski T. Górski B. Lubiński J. Breast cancer risk reduction associated with the RAD51 polymorphism among carriers of the BRCA1 5382insC mutation in Poland Cancer Epidemiol. Biomarkers Prev 2003 12 457 459 12750242 52. Seedhouse C. Faulkner R. Ashraf N. Das-Gupta E. Russell N. Polymorphisms in genes involved in homologous recombination repair interact to increase the risk of developing acute myeloid leukemia Clin. Cancer Res. 2004 10 2675 2680 10.1158/1078-0432.CCR-03-0372 15102670 53. Carling T. Imanishi Y. Gaz R.D. Arnold A. RAD51 as a candidate parathyroid tumour suppressor gene on chromosome 15q: absence of somatic mutations Clin. Endocrinol. (Oxf) 1999 51 403 407 10.1046/j.1365-2265.1999.00779.x 10583305 54. Kato M. Yano K. Matsuo F. Saito H. Katagiri T. Kurumizaka H. Yoshimoto M. Kasumi F. Akiyama F. Sakamoto G. Nagawa H. Nakamura Y. Miki Y. Identification of Rad51 alteration in patients with bilateral breast cancer J. Hum. Genet. 2000 45 133 137 10.1007/s100380050199 10807537 55. Wick W. Petersen I. Schmutzler R.K. Wolfarth B. Lenartz D. Bierhoff E. Hummerich J. Muller D.J. Stangl A.P. Schramm J. Wiestler O.D. von Deimling A. Evidence for a novel tumor suppressor gene on chromosome 15 associated with progression to a metastatic stage in breast cancer Oncogene 1996 12 973 978 8649814 56. Gonzalez R. Silva J.M. Dominguez G. Garcia J.M. Martinez G. Vargas J. Provencio M. Espana P. Bonilla F. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations Br. J. Cancer 1999 81 503 509 10.1038/sj.bjc.6690722 10507777 57. Shen C.Y. Yu J.C. Lo Y.L. Kuo C.H. Yue C.T. Jou Y.S. Huang C.S. Lung J.C. Wu C.W. Genome-wide search for loss of heterozygosity using laser capture microdissected tissue of breast carcinoma: an implication for mutator phenotype and breast cancer pathogenesis Cancer Res. 2000 60 3884 3892 10919664 58. Balsara B.R. Bell D.W. Sonoda G. De Rienzo A. du Manoir S. Jhanwar S.C. Testa J.R. Comparative genomic hybridization and loss of heterozygosity analyses identify a common region of deletion at 15q11.1–15 in human malignant mesothelioma Cancer Res. 1999 59 450 454 9927061 59. De Rienzo A. Balsara B.R. Apostolou S. Jhanwar S.C. Testa J.R. Loss of heterozygosity analysis defines a 3-cM region of 15q commonly deleted in human malignant mesothelioma Oncogene 2001 20 6245 6249 10.1038/sj.onc.1204828 11593434 60. Natrajan R. Louhelainen J. Williams S. Laye J. Knowles M.A. High-resolution deletion mapping of 15q13.2-q21.1 in transitional cell carcinoma of the bladder Cancer Res. 2003 63 7657 7662 14633686 61. Hanby A.M. Kelsell D.P. Potts H.W. Gillett C.E. Bishop D.T. Spurr N.K. Barnes D.M. Association between loss of heterozygosity of BRCA1 and BRCA2 and morphological attributes of sporadic breast cancer Int. J. Cancer 2000 88 204 208 10.1002/1097-0215(20001015)88:2<204::AID-IJC9>3.0.CO;2-1 11004669 62. Johnson S.M. Shaw J.A. Walker R.A. Sporadic breast cancer in young women: prevalence of loss of heterozygosity at p53, BRCA1 and BRCA2 Int. J. Cancer 2002 98 205 209 10.1002/ijc.10197 11857409 63. Smith S.A. Easton D.F. Evans D.G. Ponder B.A. Allele losses in the region 17q12-21 in familial breast and ovarian cancer involve the wild-type chromosome Nat. Genet. 1992 2 128 131 10.1038/ng1092-128 1303261 64. Garcia J.M. Rodriguez R. Dominguez G. Silva J.M. Provencio M. Silva J. Colmenarejo A. Millan I. Munoz C. Salas C. Coca S. Espana P. Bonilla F. Prognostic significance of the allelic loss of the BRCA1 gene in colorectal cancer Gut 2003 52 1756 1763 10.1136/gut.52.12.1756 14633957 65. Silva J.M. Gonzalez R. Provencio M. Dominguez G. Garcia J.M. Gallego I. Palacios J. Espana P. Bonilla F. Loss of heterozygosity in BRCA1 and BRCA2 markers and high-grade malignancy in breast cancer Breast Cancer Res. Treat. 1999 53 9 17 10.1023/A:1006082117266 10206068 66. Rio P.G. Maurizis J.C. Peffault de Latour M. Bignon Y.J. Bernard-Gallon D.J. Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene Int. J. Cancer 1999 80 823 826 10.1002/(SICI)1097-0215(19990315)80:6<823::AID-IJC5>3.0.CO;2-3 10074913 67. Santos S.C. Cavalli L.R. Cavalli I.J. Lima R.S. Haddad B.R. Ribeiro E.M. Loss of heterozygosity of the BRCA1 and FHIT genes in patients with sporadic breast cancer from Southern Brazil J. Clin. Pathol. 2004 57 374 377 10.1136/jcp.2003.013490 15047740",
  "plain_text": "Breast cancer is the most prevalent cancer type in women. Accumulating evidence indicates that the fidelity of double-strand break repair in response to DNA damage is an important step in mammary neoplasias. The RAD51 and BRCA1 proteins are involved in the repair of double-strand DNA breaks by homologous recombination. In this study, we evaluated loss of heterozygosity (LOH) in the RAD51 and BRCA1 regions, and their association with breast cancer. The polymorphic markers D15S118, D15S214 and D15S1006 were the focus for RAD51 , and D17S855 and D17S1323 for BRCA1 . Genomic deletion detected by allelic loss varied according to the regions tested, and ranged from 29 to 46% of informative cases for the RAD51 region and from 38 to 42% of informative cases for the BRCA1 region. 25% of breast cancer cases displayed LOH for at least one studied marker in the RAD51 region exclusively. On the other hand, 31% of breast cancer cases manifested LOH for at least one microsatellite marker concomitantly in the RAD51 and BRCA1 regions. LOH in the RAD51 region, similarly as in the BRCA1 region, appeared to correlate with steroid receptor status. The obtained results indicate that alteration in the RAD51 region may contribute to the disturbances of DNA repair involving RAD51 and BRCA1 and thus enhance the risk of breast cancer development."
}
